📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-07-30 16:25
444 analysed today
FollowTelegram
444
Today
149,845
All-time analysed
42,954
Positive
6,669
Negative
91,525
Neutral
8,629
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
23 announcements match the current filters (relevance ≥ 5).
Q1 FY27 Revenue up 34.4% YoY to Rs 176 Cr; EBITDA Margins Recover to 10.14%
Fairchem Organics reported a strong start to FY27 with Q1 revenue of Rs 176 Cr, a 34.4% YoY increase. Profitability showed a sharp recovery with a PAT of Rs 10 Cr for the quarter, already exceeding the total TTM PAT of Rs 6 Cr. EBITDA margins improved to 10.14%, driven by higher price realizations and operational efficiencies, including a 30% reduction in power consumption. Management has provided a volume growth guidance of 15-20% for the full year FY27.
Confidence: HIGH
What changedThe company has moved from a period of subdued margins and flat growth to a high-growth phase with double-digit EBITDA margins in Q1 FY27.
Why it mattersThe sharp recovery in PAT (Rs 10 Cr in one quarter vs Rs 6 Cr in the previous 12 months) suggests that cost-optimization and pricing power are returning, potentially re-rating the stock from its current high P/E levels.
Q1 FY27 Revenue: Rs 176 CrYoY Revenue Growth: 34.4%Q1 FY27 PAT: Rs 10 CrEBITDA Margin: 10.14%Volume Growth Guidance: 15% to 20%Power Consumption Reduction: 30%
📅 Short termThe stock is likely to react positively to the significant earnings beat and margin expansion compared to the previous fiscal year.
📈 Long termStructural growth depends on the successful scaling of the Isostearic acid business and maintaining the 10%+ margin profile amidst global chemical price volatility.
⚠ Risk flags
- Regulatory delays in European market registrations
- Raw material price volatility
- Geopolitical tensions in the Middle East affecting supply chains
Key Highlights
Revenue from operations grew 34.4% YoY to Rs 176 Cr in Q1 FY27.
EBITDA margin expanded to 10.14% (Rs 18 Cr), significantly higher than the FY26 OPM of 4.7%.
Management guided for 15-20% volume growth for FY27, targeting 5-7% growth per quarter.
Isostearic acid capacity utilization is targeted to reach over 80% within the next 1-2 years.
Operational costs reduced through a 30% cut in power consumption and 35% in solid fuel usage.
👀 What to Watch
Watch for the successful completion of European regulatory registrations (REACH) which is critical for the planned ramp-up of high-margin Isostearic acid exports.
755% YoY PAT Growth in Q1 FY27; Revenue up 34% to ₹176.49 Cr
Fairchem Organics reported a robust Q1 FY27 with total income rising 34.5% YoY to ₹176.49 Cr. Net profit surged to ₹10.01 Cr from ₹1.17 Cr in the same quarter last year, representing a massive 755% increase. This quarterly revenue alone represents approximately 38.4% of the company's total TTM revenue of ₹460 Cr, indicating a significant acceleration in business activity. Basic EPS for the quarter improved to ₹7.95, which already exceeds the full-year FY26 EPS of ₹4.28.
Confidence: HIGH
What changedFairchem Organics has delivered a sharp turnaround in profitability and revenue growth in Q1 FY27 after a period of subdued performance in FY25 and FY26.
Why it mattersThe significant margin expansion (PAT margin rising to 5.7% from 0.9% YoY) suggests the company may have overcome competitive pressures or successfully ramped up high-margin specialty chemical exports.
Q1 FY27 Revenue: ₹176.49 CrQ1 FY27 PAT: ₹10.01 CrYoY PAT Growth: 755%Q1 Revenue vs TTM Revenue: 38.4%Basic EPS (Q1): ₹7.95
📅 Short termThe stock is likely to react positively to this substantial earnings beat, as the quarterly profit has already surpassed the previous full year's performance.
📈 Long termIf this performance marks the successful entry into European markets for Isostearic Acid, it could lead to a structural re-rating of the business given the niche leadership position.
⚠ Risk flags
- Sustainability of high margins
- Raw material price volatility
- Regulatory compliance risks in export markets
Key Highlights
Total Income from Operations reached ₹176.49 Cr, a 34.5% increase over Q1 FY26 (₹131.20 Cr).
Net Profit After Tax jumped to ₹10.01 Cr from ₹1.17 Cr in the year-ago period.
Earnings Per Share (EPS) for the single quarter rose to ₹7.95, compared to ₹0.90 in Q1 FY26.
Profit Before Tax (PBT) stood at ₹13.64 Cr, a significant recovery from ₹1.62 Cr YoY.
Quarterly revenue of ₹176.49 Cr is ~50% higher than the immediate preceding quarter (₹117.47 Cr).
👀 What to Watch
Investors should monitor the sustainability of these improved margins and check if the growth is driven by the previously delayed Isostearic Acid exports to Europe. Watch for the full quarterly report to assess if raw material costs or product mix shifts contributed to the 755% profit surge.
Fairchem Organics Q1 FY27: PAT at Rs 10 Cr exceeds TTM total; Export target 50%
Fairchem Organics reported a significant turnaround in Q1 FY27, with a PAT of Rs 10.0 Cr, which already exceeds the total TTM PAT of Rs 6 Cr. Revenue for the quarter reached Rs 176.1 Cr, representing approximately 38% of the TTM revenue, indicating a sharp recovery in operational performance. The company is aggressively targeting the export market, aiming to increase the export mix to 50% of total sales, supported by favorable US tariffs and proposed FTAs with the EU/UK. Despite a difficult FY26 where ROCE fell to 3.88%, the Q1 EBITDA of Rs 17.9 Cr suggests a potential margin expansion phase.
Confidence: HIGH
What changedThe company has demonstrated a sharp recovery in profitability in Q1 FY27 after a period of subdued earnings and high competition in FY26.
Why it mattersThe jump in quarterly PAT suggests that the company's 'waste-to-wealth' model is regaining pricing power or volume efficiency, which is critical for a business with a high P/E ratio of 190.2.
Q1 FY27 PAT: Rs 10.0 CrQ1 FY27 Revenue: Rs 176.1 CrQ1 Revenue vs TTM Revenue: ~38.3%Export Mix Target: 50%FY26 ROCE: 3.88%
📅 Short termThe stock may react positively to the earnings turnaround, as Q1 profits alone have surpassed the previous four quarters combined.
📈 Long termLong-term value depends on successfully scaling Isostearic Acid exports to Europe and Japan and maintaining the low-cost raw material advantage.
⚠ Risk flags
- Regulatory delays in European REACH compliance
- High client concentration in the paint and coatings industry
- Volatility in vegetable oil refinery by-product availability
Key Highlights
Q1 FY27 PAT of Rs 10.0 Cr is significantly higher than the total TTM PAT of Rs 6 Cr.
Q1 FY27 Revenue reached Rs 176.1 Cr, compared to the full FY25 revenue of Rs 537.9 Cr.
Strategic target set to increase export share from current levels to 50% of total sales.
Raw material sourcing remains niche, utilizing by-products that are only 1.25% and 0.25% of processed soft oils.
Completed a share buyback worth Rs 34 Cr in January 2026.
👀 What to Watch
Investors should monitor the sustainability of these improved margins in upcoming quarters and track the progress of European REACH regulatory compliance for Isostearic Acid exports.
755% YoY PAT Growth: Fairchem Organics Reports Strong Q1 FY27 Results
Fairchem Organics reported a sharp recovery in Q1 FY27, with revenue from operations reaching ₹176.15 cr, a 34.4% increase compared to ₹131.06 cr in Q1 FY26. Net profit surged to ₹10.01 cr from ₹1.17 cr in the year-ago period, representing a 755% YoY growth. The quarterly EPS of ₹7.95 has already exceeded the entire TTM EPS of ₹4.24, indicating a significant operational turnaround. This performance follows a period of subdued demand and regulatory delays in the European market.
Confidence: HIGH
What changedThe company has delivered a significant beat on both revenue and profitability compared to the previous four quarters, reversing a trend of declining margins.
Why it mattersThe sharp jump in profitability suggests that the company may have successfully navigated competitive pressures and regulatory hurdles that previously suppressed its OPM to 4.7%.
Revenue (Q1 FY27): ₹176.15 crPAT (Q1 FY27): ₹10.01 crQ1 Revenue vs TTM Revenue: ~38.3%YoY PAT Growth: 755.5%EPS (Q1 FY27): ₹7.95
📅 Short termThe stock is likely to react positively in the short term as the earnings significantly exceed recent quarterly run-rates and historical TTM performance.
📈 Long termIf the company maintains this quarterly run-rate, it could lead to a significant re-rating of the stock, which currently trades at a high P/E due to depressed historical earnings.
⚠ Risk flags
- Raw material cost sensitivity (consumed ~68% of revenue)
- High dependence on the paint and coatings industry
- Increased finance costs
Key Highlights
Revenue from operations grew 34.4% YoY to ₹176.15 cr and 50.6% QoQ from ₹116.93 cr.
Net profit (PAT) reached ₹10.01 cr, a massive jump from ₹1.17 cr in June 2025.
Quarterly EPS stood at ₹7.95, compared to ₹0.90 in the same quarter last year.
Segment results for Specialty Chemicals improved to ₹15.47 cr from ₹2.62 cr YoY.
Finance costs increased to ₹1.84 cr from ₹1.01 cr in the year-ago quarter.
👀 What to Watch
Investors should monitor management commentary regarding the sustainability of these margins and the status of Isostearic Acid exports to Europe. The key factor to watch is whether this volume growth is a one-off recovery or a structural ramp-up following REACH compliance.
Rs 173.99 Cr: CARE Reaffirms 'CARE A; Stable' Rating; Long-term Bank Facilities Enhanced
CARE Ratings has reaffirmed Fairchem Organics' long-term credit rating at 'CARE A; Stable' and short-term rating at 'CARE A1'. A significant detail is the enhancement of rated long-term bank facilities from Rs 123.99 crore to Rs 173.99 crore. This Rs 50 crore increase in rated limits represents approximately 11% of TTM revenue and 19% of the current net worth, providing additional financial headroom. The reaffirmation comes despite a challenging period where OPM has moderated to 4.7% and TTM PAT stands at Rs 6 crore.
Confidence: HIGH
What changedCARE Ratings reaffirmed the company's credit ratings while increasing the total amount of rated long-term bank facilities by Rs 50 crore.
Why it mattersThe reaffirmation validates the company's creditworthiness despite recent profitability pressures, while the enhanced limits provide the necessary liquidity to support future growth or working capital needs.
Enhanced Long-term Facilities: Rs 173.99 CrPrevious Long-term Facilities: Rs 123.99 CrTotal Rated Facilities vs TTM Revenue: ~39.4%Total Rated Facilities vs Net Worth: ~68.9%
📅 Short termThe reaffirmation is likely to be viewed neutrally by the market as it maintains the status quo on credit quality.
📈 Long termThe increased credit limits support the company's long-term strategy to expand its specialty chemical portfolio and target the European export market.
⚠ Risk flags
- Moderating profitability (OPM 4.7%)
- Regulatory delays in European market entry
- High P/E ratio of 159.1 relative to current earnings
Key Highlights
Long-term bank facilities rating reaffirmed at 'CARE A; Stable'
Short-term bank facilities rating reaffirmed at 'CARE A1'
Rated long-term bank facilities enhanced by Rs 50 crore to a total of Rs 173.99 crore
Total rated bank facilities (Long + Short term) now stand at approximately Rs 181.24 crore
Rating action follows an annual review by CARE Ratings Limited
👀 What to Watch
Monitor the utilization of the additional Rs 50 crore credit limit to see if it funds the strategic ramp-up of Isostearic Acid exports once European regulatory hurdles are cleared.
Fairchem Organics Q4 FY26: PAT at ₹3.7 Cr; Targets 80% Capacity Utilization in FY27
Fairchem Organics reported a 14.5% YoY decline in annual revenue to ₹460 crores for FY26, with a full-year net profit of ₹6.2 crores. Despite the annual dip, Q4 FY26 showed signs of recovery with EBITDA margins improving to 6.9% due to better domestic price realizations and reduced Chinese dumping. The company successfully completed a buyback of 4.25 lakh shares, increasing promoter holding to 63.2%. Management is optimistic about FY27, targeting 80% capacity utilization and an increase in export share from 9% to 20%.
Key Highlights
FY26 revenue declined 14.5% to ₹460 crores, with Q4 revenue at ₹117 crores.
EBITDA margins improved to 6.9% in Q4 FY26, up from the full-year average of 4.7%.
Management targets 80% capacity utilization in FY27 and 95% within two years.
Export revenue share is projected to grow from the current 9% to approximately 20%.
Promoter holding increased from 61.2% to 63.2% following a buyback of 4.25 lakh shares.
👀 What to Watch
Investors should monitor the company's ability to scale capacity utilization and exports as guided, which could lead to significant operating leverage. The reduction in Chinese dumping and recovery in the paint industry are key positive triggers to watch.
Fairchem Organics Q4 FY26 PAT Surges 521% YoY to ₹37 Mn Despite Marginal Revenue Dip
Fairchem Organics reported a sharp recovery in profitability for Q4 FY26, with PAT jumping 521.8% YoY to ₹37 million, driven by EBITDA margins expanding to 6.87%. While quarterly revenue saw a slight decline of 3.2% YoY to ₹1,169 million due to weak demand from the paint industry, domestic realizations improved as imports reduced. The company is pivoting towards high-value products like Isostearic Acid and expanding its export footprint in the US and EU. For the full year FY26, the company recorded a revenue of ₹4,596 million and a PAT of ₹62 million.
Key Highlights
Q4 FY26 PAT increased by 521.8% YoY to ₹37 million compared to ₹6 million in Q4 FY25.
EBITDA margins expanded by 321 bps to 6.87% in Q4 FY26 from 3.66% in the year-ago period.
Revenue for the quarter stood at ₹1,169 million, reflecting a minor decline of 3.2% YoY.
Successfully completed a share buy-back worth ₹340 million in January 2026.
Strategic focus on forward integration into Isostearic Acid to target high-growth global markets.
👀 What to Watch
Investors should focus on the significant margin recovery and the company's ability to maintain profitability despite revenue headwinds in the paint sector. The focus on value-added exports and the recent buy-back indicate management's confidence in the long-term business model.
Fairchem Organics FY26 Revenue Drops 14.5% to ₹459.6 Cr; Recommends ₹1 Dividend
Fairchem Organics reported a decline in annual revenue from operations to ₹45,964.82 Lakhs for FY26, down from ₹53,789.84 Lakhs in FY25. For the quarter ended March 31, 2026, revenue stood at ₹11,692.84 Lakhs, showing a slight recovery from the preceding quarter but remaining lower than the year-ago period. The Board has recommended a dividend of ₹1.00 per equity share (10% of face value) for the financial year. Additionally, the company has proposed the re-appointment of Sudhin Choksey as an Independent Director for a second five-year term starting in 2027.
Key Highlights
Annual Revenue from Operations decreased by 14.5% year-on-year to ₹45,964.82 Lakhs in FY26.
Quarterly revenue for Q4 FY26 was ₹11,692.84 Lakhs compared to ₹12,078.07 Lakhs in Q4 FY25.
Board recommended a dividend of ₹1.00 per equity share (10% of face value) with a record date of July 20, 2026.
Sudhin Choksey re-appointed as Independent Director for a second term from February 2027 to February 2032.
Cost of materials consumed for FY26 stood at ₹37,419.19 Lakhs, down from ₹41,974.92 Lakhs in the previous year.
👀 What to Watch
Investors should exercise caution as the company has seen a significant contraction in annual revenue. Monitor the upcoming AGM on July 27, 2026, for management commentary on growth recovery and margin sustainability.
Fairchem Organics FY26 Revenue at ₹459.6 Cr; Recommends ₹1.00 Dividend
Fairchem Organics reported an annual revenue of ₹45,964.82 lakhs for FY26, a decline from ₹53,789.84 lakhs in the previous fiscal year. The Board has recommended a dividend of ₹1.00 per equity share (10% of face value), with the record date set for July 20, 2026. While annual performance saw a dip, Q4 FY26 revenue of ₹11,692.84 lakhs showed sequential improvement over Q3 FY26. Additionally, the company has proposed the re-appointment of Sudhin Choksey as an Independent Director for a second five-year term.
Key Highlights
Annual Revenue from Operations decreased 14.5% YoY to ₹45,964.82 lakhs in FY26.
Recommended a dividend of ₹1.00 per equity share (10% on par value of ₹10).
Fixed July 20, 2026, as the Record Date for determining dividend eligibility.
Q4 FY26 revenue stood at ₹11,692.84 lakhs, up from ₹10,013.40 lakhs in Q3 FY26.
Re-appointment of Sudhin Choksey as Independent Director for the period 2027-2032.
👀 What to Watch
Investors should monitor the sequential recovery in quarterly revenue despite the year-on-year decline. The stock remains a watch for margin recovery in the specialty chemicals sector, with a modest dividend payout confirmed.
Fairchem Organics FY26 Revenue Declines 14.5% to ₹459.65 Cr; Recommends ₹1 Dividend
Fairchem Organics reported a decline in annual revenue from operations to ₹459.65 crore for FY26, compared to ₹537.90 crore in FY25. The company's quarterly revenue for Q4 FY26 also saw a slight dip to ₹116.93 crore from ₹120.78 crore in the same period last year. Despite the revenue contraction, the board has recommended a dividend of ₹1.00 per equity share (10% of face value). The company also announced the re-appointment of Sudhin Choksey as an Independent Director for a second five-year term starting February 2027.
Key Highlights
Annual Revenue from Operations decreased by 14.5% YoY to ₹459.65 crore in FY26.
Quarterly Revenue for Q4 FY26 stood at ₹116.93 crore, down from ₹120.78 crore in Q4 FY25.
Board recommended a dividend of ₹1.00 per equity share (10% on par value of ₹10).
Cost of materials consumed for the full year reduced to ₹374.19 crore from ₹419.75 crore.
Record date for dividend eligibility is fixed as July 20, 2026.
👀 What to Watch
Investors should monitor the company's ability to arrest the revenue decline and check for management commentary on raw material price volatility. The stock may face short-term pressure due to the year-on-year top-line contraction.
Fairchem Organics FY26 Revenue Drops 14.5% YoY to ₹459.6 Cr; Recommends ₹1 Dividend
Fairchem Organics reported a significant 14.5% decline in annual revenue for FY26, totaling ₹45,964.82 lakhs compared to ₹53,789.84 lakhs in FY25. However, Q4 FY26 showed a sequential recovery with revenue of ₹11,692.84 lakhs, up 16.8% from the previous quarter. The Board has recommended a dividend of ₹1.00 per share (10% of face value) and set July 20, 2026, as the record date. Additionally, the company has proposed the re-appointment of Sudhin Choksey as an Independent Director for a second five-year term.
Key Highlights
Annual Revenue from Operations decreased by 14.5% YoY to ₹459.65 crore in FY26
Q4 FY26 Revenue stood at ₹116.93 crore, showing a 16.8% sequential growth over Q3 FY26
Recommended a dividend of ₹1.00 per equity share (10% payout) for the financial year
Record date for dividend eligibility is fixed as July 20, 2026
Proposed re-appointment of Shri Sudhin Choksey as Independent Director from 2027 to 2032
👀 What to Watch
The significant year-on-year revenue contraction is a concern, although the sequential improvement in Q4 suggests a potential bottoming out. Investors should monitor the company's ability to sustain this quarterly recovery and manage raw material costs before increasing exposure.
Fairchem Organics Recommends ₹1 Dividend; FY26 Revenue at ₹459.65 Crore
Fairchem Organics has recommended a final dividend of ₹1 per share (10% of face value) for the financial year ended March 31, 2026. The company reported a year-on-year decline in annual revenue from operations, which fell to ₹45,964.82 lakhs from ₹53,789.84 lakhs. However, the fourth quarter showed sequential growth with revenue at ₹11,692.84 lakhs compared to ₹10,013.40 lakhs in Q3. The record date for dividend eligibility is set for July 20, 2026.
Key Highlights
Recommended a final dividend of ₹1.00 per equity share (10% on par value of ₹10)
Annual revenue from operations decreased by 14.5% YoY to ₹45,964.82 lakhs
Q4 FY26 revenue showed a sequential recovery of 16.8% over Q3 FY26
Record date for dividend payment fixed as July 20, 2026
Board approved re-appointment of Sudhin Choksey as Independent Director for a second term
👀 What to Watch
Investors should monitor the company's ability to sustain the sequential revenue growth seen in Q4 to offset the annual decline. The modest dividend provides a small yield, but the focus remains on operational recovery.
Fairchem Organics FY26 Revenue Declines 14.5% to ₹459.6 Cr; ₹1 Dividend Recommended
Fairchem Organics reported a 14.5% year-on-year decline in annual revenue, totaling ₹45,964.82 lakhs for FY26 compared to ₹53,789.84 lakhs in FY25. The company's Q4 performance showed a slight sequential improvement over Q3 but remained lower than the previous year's corresponding quarter. To reward shareholders despite the revenue dip, the board has recommended a dividend of ₹1.00 per share. Additionally, the company confirmed the re-appointment of an Independent Director and set the AGM for July 27, 2026.
Key Highlights
FY26 Revenue from Operations fell to ₹45,964.82 lakhs from ₹53,789.84 lakhs in FY25.
Q4 FY26 Revenue stood at ₹11,692.84 lakhs, a 3.2% decrease from ₹12,078.07 lakhs in Q4 FY25.
Recommended a final dividend of 10% (₹1.00 per equity share) for the financial year.
Fixed July 20, 2026, as the record date for determining dividend eligibility.
Statutory auditors provided an unmodified opinion on the audited financial results.
👀 What to Watch
Investors should exercise caution due to the double-digit decline in annual revenue and analyze the full report for potential margin compression. Monitor the stock for signs of demand recovery in the specialty chemicals sector before increasing exposure.
Fairchem Organics Q3 FY26 Revenue Drops 12% to ₹100 Cr; EBITDA Margins Squeeze to 4.2%
Fairchem Organics reported a weak Q3 FY26 with revenue declining 12% YoY to ₹100 crores and EBITDA falling to ₹4 crores due to lower demand from the paint sector and Chinese dumping. Profitability was severely impacted by a duty inversion where raw materials face 16.5% duty while finished products face only 7.5%. Management expects a gradual recovery starting H2 FY27, supported by new trade agreements with the US and EU and the launch of an animal feed plant. The company is also working on cost-saving measures and domestic catalyst replacement to improve margins.
Key Highlights
Q3 Revenue stood at ₹100 crores, a 12% YoY decline, while 9M FY26 revenue fell 18% to ₹343 crores.
EBITDA margins compressed to 4.2% in Q3 and 3.97% for 9M FY26, impacted by elevated raw material costs.
Adjusted PAT for the quarter was ₹60 lakhs (0.6% margin) after an ₹88 lakh exceptional item for labor code implementation.
Management highlighted a duty disadvantage with raw material duties at 16.5% versus 7.5% for imported dimer acid.
Animal feed plant is ready and awaiting GMP certification, with a new value-added product slated for Q3 FY27.
👀 What to Watch
Investors should remain cautious as the company faces significant margin pressure from Chinese imports and high raw material duties. Monitor the recovery in export volumes to the US and the commissioning of the animal feed plant in the coming quarters for signs of a turnaround.
Fairchem Organics Q3 FY26 PAT Plummets 83% YoY to INR 6 Mn Amid Margin Pressure
Fairchem Organics reported a weak performance for Q3 FY26, with revenue declining 12% YoY to INR 1,001 Mn and PAT (excluding exceptional items) dropping 83% to INR 6 Mn. EBITDA margins contracted significantly to 4.20% from 6.87% a year ago, driven by elevated raw material costs and aggressive pricing from Chinese competitors. The company faced headwinds in the domestic paint segment due to a new market entrant and a temporary halt in US exports. Management expects a recovery in high-margin exports following recent tariff adjustments in the US and potential FTAs with the UK and EU.
Key Highlights
Q3 FY26 Revenue fell 11.9% YoY to INR 1,001 Mn, while 9M FY26 revenue dropped 17.8% to INR 3,427 Mn.
EBITDA for Q3 FY26 declined by 46.2% YoY to INR 42 Mn, with margins shrinking by 267 bps to 4.20%.
PAT (excluding exceptional items) saw a sharp decline of 82.9% YoY, reaching only INR 6 Mn for the quarter.
Raw material costs remained high due to a 16.5% custom duty compared to the original 5.5%, impacting Dimer Acid margins.
Successfully concluded a buyback of INR 340 Mn in January 2026, increasing promoter holding to 63.25%.
👀 What to Watch
Investors should exercise caution as the company faces intense margin pressure from high input costs and Chinese competition. Monitor the ramp-up of exports to the US and Europe as the primary catalyst for a potential recovery in profitability.
Fairchem Organics Reports Q3 FY26 Net Loss of ₹9.71 Lakhs; Revenue Down 11.8% YoY
Fairchem Organics reported a weak performance for the quarter ended December 31, 2025, with revenue from operations declining 11.8% YoY to ₹10,013.40 Lakhs. The company swung to a net loss of ₹9.71 Lakhs from a profit of ₹351.78 Lakhs in the previous year's corresponding quarter. Performance was impacted by an exceptional charge of ₹88.27 Lakhs related to new labor code regulations and overall margin compression. For the nine-month period, net profit plummeted by over 91% YoY to ₹184.87 Lakhs.
Key Highlights
Revenue from operations decreased to ₹10,013.40 Lakhs in Q3 FY26 from ₹11,357.08 Lakhs in Q3 FY25.
Reported a net loss of ₹9.71 Lakhs for the quarter compared to a profit of ₹351.78 Lakhs YoY.
Nine-month PAT (9M FY26) stood at ₹184.87 Lakhs, a 91.3% decline from ₹2,138.06 Lakhs in 9M FY25.
Recognized an exceptional expense of ₹88.27 Lakhs due to the implementation of the Code on Wages, 2019.
Completed a buyback of 4,25,000 equity shares at ₹800 per share for a total of ₹34 Crores in January 2026.
👀 What to Watch
The significant drop in profitability and revenue suggests severe margin pressure in the specialty chemicals segment. Investors should remain cautious and monitor the company's ability to pass on costs and improve operational efficiency in upcoming quarters.
Fairchem Organics Reports Q3 FY26 Net Loss of ₹9.71 Lakhs; Revenue Down 11.8% YoY
Fairchem Organics Limited reported a challenging Q3 FY26, with revenue from operations declining to ₹10,013.40 Lakhs from ₹11,357.08 Lakhs YoY. The company swung to a net loss of ₹9.71 Lakhs for the quarter, significantly impacted by an exceptional item of ₹88.27 Lakhs related to new labor code regulations. For the nine-month period ending December 2025, net profit plummeted to ₹184.87 Lakhs compared to ₹2,138.06 Lakhs in the previous year. Despite the weak earnings, the company successfully completed a ₹34 Crore share buyback at ₹800 per share in January 2026.
Key Highlights
Revenue from operations decreased by 11.8% YoY to ₹10,013.40 Lakhs in Q3 FY26.
Reported a Net Loss of ₹9.71 Lakhs in Q3 FY26 versus a Net Profit of ₹351.78 Lakhs in Q3 FY25.
Exceptional charge of ₹88.27 Lakhs recognized for employee benefit obligations under new Labour Codes.
Completed buyback of 4,25,000 shares at ₹800 each, totaling ₹34 Crores, with shares extinguished on Jan 27, 2026.
Nine-month revenue stood at ₹34,271.98 Lakhs, down from ₹41,711.77 Lakhs in the prior year period.
👀 What to Watch
The sharp decline in profitability and revenue suggests significant operational headwinds in the specialty chemicals sector. Investors should remain cautious and monitor for margin stabilization, as the recent buyback at ₹800 provides a psychological floor but does not offset the weak earnings performance.
Fairchem Organics Completes Extinguishment of 4.25 Lakh Equity Shares Post-Buyback
Fairchem Organics has successfully completed the extinguishment of 4,25,000 equity shares following its recent buyback program. This action has reduced the company's total paid-up share capital from 1,30,20,902 shares to 1,25,95,902 shares, representing a reduction of approximately 3.26%. The extinguishment was finalized on January 27, 2026, in compliance with SEBI Buy-Back Regulations. Such a reduction in the share base typically leads to an improvement in Earnings Per Share (EPS) and Return on Equity (ROE) for existing shareholders.
Key Highlights
Extinguished 4,25,000 equity shares of face value Rs. 10 each on January 27, 2026
Total paid-up share capital reduced from INR 13.02 crore to INR 12.60 crore
Total outstanding equity shares decreased from 1,30,20,902 to 1,25,95,902
The buyback tendering period was conducted between January 8 and January 14, 2026
The extinguishment was confirmed by CDSL and verified by secretarial auditors
👀 What to Watch
The reduction in equity base is a positive development that enhances shareholder value through improved financial ratios. Investors should hold their positions as the lower share count will marginally boost future EPS.
Fairchem Organics Completes Buyback of 76,045 Equity Shares at ₹1,315 Per Share
Fairchem Organics Limited has successfully concluded its share buyback program through the tender offer route. The company repurchased 76,045 equity shares at a price of ₹1,315 per share, involving a total capital outlay of ₹10 crore. This buyback has resulted in a reduction of the total paid-up equity capital, which may lead to a marginal improvement in Earnings Per Share (EPS) for remaining shareholders.
Key Highlights
Repurchased 76,045 equity shares at a premium price of ₹1,315 per share.
Total buyback size amounted to ₹10 crore, excluding transaction costs and taxes.
The buyback was conducted via the Tender Offer route as per SEBI regulations.
Post-buyback, the total number of equity shares has been reduced, potentially enhancing return ratios.
👀 What to Watch
As the buyback is now complete and shares have been extinguished, investors should focus on the company's operational performance and the resulting impact on EPS in the next quarterly report.
Fairchem Organics Announces Buyback of 4.25 Lakh Shares at ₹800 Per Share via Tender Offer
Fairchem Organics Limited has issued a Letter of Offer for the buyback of up to 4,25,000 equity shares at a price of ₹800 per share, totaling ₹3,400 lakhs. The buyback represents 3.26% of the total equity and 16% of the company's paid-up capital and free reserves as of March 2025. The process will be conducted via the tender offer route, with the acceptance window open from January 8 to January 14, 2026. The record date for determining eligibility was January 5, 2026.
Key Highlights
Buyback of 4,25,000 shares at a fixed price of ₹800 per share via tender route
Total buyback size of ₹3,400 lakhs represents 16% of the company's net worth
Small shareholder entitlement ratio is approximately 29 shares for every 488 shares held
General category entitlement ratio is approximately 55 shares for every 606 shares held
Tendering period scheduled from January 8, 2026, to January 14, 2026
👀 What to Watch
Eligible shareholders should evaluate the premium of the ₹800 buyback price over the current market price and consider tendering their shares before the January 14 deadline.
